Effects of dopaminergic treatment on striatal dopamine turnover in de novo Parkinson disease.
Storch A, Wolz M, Beuthien-Baumann B, Löhle M, Herting B, Schwanebeck U, Oehme L, van den Hoff J, Perick M, Grählert X, Kotzerke J, Reichmann H.
Storch A, et al. Among authors: oehme l.
Neurology. 2013 May 7;80(19):1754-61. doi: 10.1212/WNL.0b013e3182918c2d. Epub 2013 Apr 10.
Neurology. 2013.
PMID: 23576623
Clinical Trial.